TriLink Headquarters Expansion

Construction is underway on two facility expansions, allowing us to add custom plasmid DNA manufacturing as part of our complete mRNA solutions. Contact us for more details on plasmid services and availability. Additional cGMP suites to support CleanCap^® mRNA capping production will be completed in early 2021.